Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleural effusions in hematologic malignancies.

Michael G Alexandrakis1, Freda H Passam, Despina S Kyriakou

  • 1Department of Hematology, University Hospital of Heraklion, and Medical School, University of Crete, Greece.

Chest
|April 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ribosomal Translation and Display Selection of Cyclic Glycopeptides through Genetic Reprogramming.

Journal of the American Chemical Society·2026
Same author

Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

ERJ open research·2026
Same author

Managing patients with a history of arterial disease and new venous thromboembolism.

Hematology. American Society of Hematology. Education Program·2025
Same author

P selectin promotes SARS-CoV-2 interactions with platelets and the endothelium.

The Journal of clinical investigation·2025
Same author

Endo-chip laser-induced thrombus formation: a vessel-on-chip model for in vitro testing of antithrombotic agents.

Blood vessels, thrombosis & hemostasis·2025
Same author

SEC61B regulates calcium flux and platelet hyperreactivity in diabetes.

The Journal of clinical investigation·2025
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
Same journal

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026
Same journal

Eisenmenger Syndrome: The Pulmonology Perspective.

Chest·2026
See all related articles

Hematologic malignancies frequently cause pleural effusions, particularly lymphomas. Treatment of the primary cancer often resolves effusions, but some cases may require pleurodesis.

Area of Science:

  • Oncology
  • Pulmonology
  • Hematology

Background:

  • Pleural effusions are common in hematologic malignancies.
  • Lymphomas, especially with mediastinal involvement, show higher frequencies (20-30%).
  • Leukemias and myelodysplastic syndromes rarely present with pleural involvement.

Purpose of the Study:

  • To review the occurrence and management of pleural effusions in hematologic malignancies.
  • To highlight common causes and treatment strategies for these effusions.

Main Methods:

  • Review of literature on hematologic malignancies and pleural effusions.
  • Analysis of the frequency and clinical presentation of pleural effusions in various hematologic cancers.
  • Discussion of etiological factors and therapeutic approaches.

Related Experiment Videos

Main Results:

  • Pleural effusions occur in nearly all hematologic malignancies.
  • Bone marrow transplant recipients have a 10-30% incidence of pleural effusions.
  • Etiologies include drug toxicity, infection, secondary malignancy, and autoimmune conditions.

Conclusions:

  • Pleural effusions in hematologic malignancies often resolve with primary disease treatment.
  • Refractory or relapsing effusions may necessitate pleurodesis.
  • Careful investigation for underlying causes is crucial.